Sanofi Pasteur, the vaccines division of the pharmaceutical group Sanofi-Aventis, on Thursday announced the company had begun testing its dengue fever vaccine in a Phase III clinical trial in Australia, Dow Jones/Wall Street Journal reports. “Sanofi-Aventis already performed earlier clinical tests on children and adults with the vaccine in the U.S., Asia and Latin America,” Dow Jones/Wall Street Journal adds (Landauro, 11/4).
Also In Global Health News: WFP In North Korea; Maternal Health In Indonesia; Possible Vaccine Contamination; GM Mosquitoes In Malaysia; Mobile Micro-Insurance In Kenya
World Food Programme Director Visits North Korea, Tours Food Factory U.N. World Food Programme (WFP)Â Executive Director Josette Sheeran and former U.S. Special Envoy Jack Pritchard arrived in North Korea Tuesday, Agence France-Presse reports (11/2). The visit is WFP’s “first top-level visit to the communist country in nearly 10 years,” the…
The Guardian concluded its three-year Katine project in north-eastern Uganda, which “tracked the implementation of a development project focusing on five aspects of deprivation: health, education, water and sanitation, livelihoods and governance,” the newspaper writes. Together with the help of Barclays, Guardian readers, Amref and CARE International, the newspaper covered “an extraordinary picture of the ups and downs, strains and stresses of a development project” (Bunting, 10/30).
“Eliminating malaria can be achieved only with repeated investment over the long term and will require a major shift in policy and funding,” according to some experts, Reuters reports (Kelland, 10/29). The Associated Press reports that the feasibility of “eliminating malaria was examined in a series Friday in the Lancet. Experts analyzed issues like the practicalities of wiping out malaria and its financial costs” (10/29).
Global Fund Will Make ‘Every Possible Effort’ To Raise Additional Resources: Although pledges to the Global Fund to Fight AIDS, Tuberculosis and Malaria at its recent replenishment meeting did not meet “the lowest estimate of demand,” the Fund “will make every possible effort to raise the additional resources that we…
Polio Vaccination Campaign Targeting 72M Children In 15 African Countries Announced; Ugandan Health Authorities Declare Polio Outbreak
The WHO on Tuesday announced a mass polio immunization campaign in 15 African countries targeting a total of 72 million children, Agence France-Presse reports. “Polio has spread again in recent years with cases imported from some of the four endemic nations in Asia and Africa, mainly Nigeria, in a setback to global attempts to eradicate the crippling and sometimes lethal disease,” the news service writes (10/26).
The bivalent oral polio vaccine (bOPV) was found to induce a “significantly higher immune response” than the existing trivalent oral polio vaccine (tOPV), according to a study published on Tuesday in the journal Lancet, Reuters reports (Kelland, 10/26).
Progress, Challenges In Curbing Neglected Tropical Diseases: “The effect of 30 years of neglect for these diseases in research and development of new diagnostics and drugs, and, crucially, in investing in training and education in vector-borne diseases, is evident. Most current drugs for neglected tropical diseases are old, and the…
SciDev.Net reports on an HIV vaccine research collaboration between researchers from India and South Africa to launch by the end of 2010.
A new vaccine for meningitis, MenAfriVac, “offers hope of an escape from one of the world’s deadliest, most disabling and infectious diseases,” BBC writes. The vaccine was developed by non-governmental organization PATH in partnership with the WHO and “created specifically for Africa.”